Specifically, NDUFA4L2 is overexpressed in clear cell RCC (ccRCC); its mRNA level is correlated with tumor stage and overall survival time [50, 51]; and the association of NDUFA4L2 with ccRCC is regulated by ELK1 [52]. The gene discussed is ELK1; the disease is neoplasm.